Skip to main content

Advertisement

Log in

Loss of NHEJ1 Protein Due to a Novel Splice Site Mutation in a Family Presenting with Combined Immunodeficiency, Microcephaly, and Growth Retardation and Literature Review

  • Original Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Introduction

Non-homologous end joining gene 1 (NHEJ1) defect is a rare form of primary immune deficiency. Very few cases have been described from around the world.

Purpose

We are reporting the first family from the Arabian Gulf with three siblings presenting with combined immunodeficiency (CID), microcephaly, and growth retardation due to a novel NHEJ1 splice site mutation, in addition to a review of the previously published literature on this subject.

Methods

Patients’ clinical, immunological, and laboratory features were examined. Samples were subjected to targeted next-generation sequencing (NGS). The pathogenic change in NHEJ1 was confirmed by Sanger sequencing, then further assessed at the RNA and protein levels.

Results

Patients were found to have a homozygous splice site mutation immediately downstream of exon 3 in NHEJ1 (c.390 + 1G > C). This led to two distinct mRNA products, one of which demonstrated skipping of the last 69 basepairs (bp) of exon 3 while the other showed complete skipping of the entire exon. Although both deletions were in-frame, immunoblotting did not reveal any NHEJ1 protein products in patient cells, indicating a null phenotype.

Conclusion

Patients presenting with CID, microcephaly, and growth retardation should be screened for NHEJ1 gene mutations. We discuss our data in the context of one of our patients who is still alive at the age of 30 years, without transplantation, and who is the longest known survivor of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Burma S, Chen BP, Chen DJ. Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst). 2006;5(9–10):1042–8.

    Article  CAS  Google Scholar 

  2. Ahnesorg P, Smith P, Jackson SP. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell. 2006;124(2):301–13.

    Article  CAS  Google Scholar 

  3. Lu H, et al. Length-dependent binding of human XLF to DNA and stimulation of XRCC4.DNA ligase IV activity. J Biol Chem. 2007;282(15):11155–62.

    Article  CAS  Google Scholar 

  4. Tsai CJ, Kim SA, Chu G. Cernunnos/XLF promotes the ligation of mismatched and noncohesive DNA ends. Proc Natl Acad Sci U S A. 2007;104(19):7851–6.

    Article  CAS  Google Scholar 

  5. Deshpande RA, Wilson TE. Modes of interaction among yeast Nej1, Lif1 and Dnl4 proteins and comparison to human XLF, XRCC4 and Lig4. DNA Repair (Amst). 2007;6(10):1507–16.

    Article  CAS  Google Scholar 

  6. Xing M, et al. Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway. Nat Commun. 2015;6:6233.

    Article  CAS  Google Scholar 

  7. Buck D, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell. 2006;124(2):287–99.

    Article  CAS  Google Scholar 

  8. Dutrannoy V, et al. Clinical variability and novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome-like phenotype. Hum Mutat. 2010;31(9):1059–68.

    Article  CAS  Google Scholar 

  9. Faraci M, et al. Unrelated hematopoietic stem cell transplantation for Cernunnos-XLF deficiency. Pediatr Transplant. 2009;13(6):785–9.

    Article  CAS  Google Scholar 

  10. Al-Mousa H, et al. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases. J Allergy Clin Immunol. 2016;137(6):1780–7.

    Article  CAS  Google Scholar 

  11. Al-Saud BK, et al. Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients. J Clin Immunol. 2013;33(8):1325–35.

    Article  CAS  Google Scholar 

  12. Yu Y, et al. DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks. DNA Repair (Amst). 2008;7(10):1680–92.

    Article  CAS  Google Scholar 

  13. Gennery AR. Primary immunodeficiency syndromes associated with defective DNA double-strand break repair. Br Med Bull. 2006;77-78:71–85.

    Article  CAS  Google Scholar 

  14. IJspeert H, et al. XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination. Blood. 2016;128(5):650–9.

    Article  CAS  Google Scholar 

  15. Cagdas D, et al. Two SCID cases with Cernunnos-XLF deficiency successfully treated by hematopoietic stem cell transplantation. Pediatr Transplant. 2012;16(5):E167–71.

    Article  Google Scholar 

  16. Turul T, Tezcan I, Sanal O. Cernunnos deficiency: a case report. J Investig Allergol Clin Immunol. 2011;21(4):313–6.

    CAS  PubMed  Google Scholar 

  17. Carrillo J, et al. Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening. Hum Mol Genet. 2017;26(10):1900–14.

    Article  CAS  Google Scholar 

  18. Patiroglu T, et al. A case of XLF deficiency presented with diffuse large B cell lymphoma in the brain. Clin Immunol. 2015;161(2):394–5.

    Article  CAS  Google Scholar 

  19. Cantagrel V, et al. Truncation of NHEJ1 in a patient with polymicrogyria. Hum Mutat. 2007;28(4):356–64.

    Article  CAS  Google Scholar 

  20. Avagyan S, et al. Hematopoietic stem cell dysfunction underlies the progressive lymphocytopenia in XLF/Cernunnos deficiency. Blood. 2014;124(10):1622–5.

    Article  CAS  Google Scholar 

  21. Meyer-Bahlburg A, Dressler F, Baumann U. Chronic arthritis in a boy with Cernunnos immunodeficiency. Clin Immunol. 2014;154(1):47–8.

    Article  CAS  Google Scholar 

  22. Cipe FE, et al. Cernunnos/XLF deficiency: a syndromic primary immunodeficiency. Case Rep Pediatr. 2014;2014:614238.

    PubMed  PubMed Central  Google Scholar 

  23. Slack J et al. Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders. J Allergy Clin Immunol. 2017.

  24. Malivert L, et al. Delineation of the Xrcc4-interacting region in the globular head domain of cernunnos/XLF. J Biol Chem. 2010;285(34):26475–83.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all family members for their enthusiastic participation. We acknowledge the Saudi Human Genome Project for infrastructure and informatics support relating to the targeted NGS. We are also grateful to all the immunology staff, and to the sequencing core facility, at KFSH&RC for their invaluable assistance. This work was supported by the National Science, Technology and Innovation Plan program of Saudi Arabia (KACST 14-MED316-20).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Farrukh Sheikh, Abbas Hawwari or Anas M. Alazami.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sheikh, F., Hawwari, A., Alhissi, S. et al. Loss of NHEJ1 Protein Due to a Novel Splice Site Mutation in a Family Presenting with Combined Immunodeficiency, Microcephaly, and Growth Retardation and Literature Review. J Clin Immunol 37, 575–581 (2017). https://doi.org/10.1007/s10875-017-0423-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-017-0423-5

Keywords

Navigation